Fayetteville, AR

Fayetteville, Arkansas 72703

0 studies enrolling now · 2 studies all time

What they study most

Comorbidity, Diabetic Macular Edema (DME), Myocardial Infarction

Studies at this site

• A Study of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME — Running, not enrolling
• Web-Enhanced Guideline Implementation for Post MI CBOC Patients — Completed